MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$12M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
Proceeds from abl facility
Impairment and (gain) loss on sa...
Proceeds from disposition of hos...
Others
Negative Cash Flow Breakdown
Salaries and benefits
Repayments of long-term indebted...
Other segment items
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net operating revenues
2,825
2,965
3,106
3,087
Salaries and benefits
1,237
1,322
1,356
1,357
Supplies
402
441
446
460
Contract labor
-
-
-
39
Medical specialist fees
158
163
169
165
Other segment items
704
734
859
696
Depreciation and amortization
108
114
109
106
Interest expense
207
214
221
218
Interest income
1
1
0
1
Impairment and (gain) loss on sale of businesses, net
-172
-90
-164
21
Loss (gain) from early extinguishment of debt
-4
-8
-8
-33
Equity in earnings of unconsolidated affiliates
2
4
0
5
Provision for income taxes
76
89
61
-173
Net income
104
-25
160
171
Depreciation and amortization
108
114
109
106
Deferred income taxes
0
0
18
-270
Stock-based compensation expense
2
3
4
0
Impairment and (gain) loss on sale of businesses, net
-172
-90
-164
21
Loss (gain) from early extinguishment of debt
-4
-8
-8
-33
Other non-cash expenses, net
-40
-40
-39
-42
Patient accounts receivable
18
141
-24
-101
Supplies, prepaid expenses and other current assets
-77
97
-39
-18
Accounts payable, accrued liabilities and income taxes
6
-128
50
-132
Other
63
-19
21
21
Net cash (used in) provided by operating activities
88
-297
266
69
Acquisitions of facilities and other related businesses
48
5
0
1
Purchases of property and equipment
76
76
94
65
Proceeds from disposition of hospitals and other ancillary operations
110
1,108
242
-1
Proceeds from sale of property and equipment
0
-
0
3
Purchases of available-for-sale debt securities and equity securities
23
42
32
35
Proceeds from sales of available-for-sale debt securities and equity securities
18
45
36
29
Purchases of investments in unconsolidated affiliates
1
-
0
0
Increase in other investments
3
7
10
11
Net cash provided by investing activities
-23
1,023
142
-81
Repurchase of restricted stock shares for payroll tax withholding requirements
0
2
0
0
Deferred financing costs and other debt-related costs
2
7
7
7
Proceeds from noncontrolling investors in joint ventures
0
-
0
1
Redemption of noncontrolling investments in joint ventures
-
-
1
2
Distributions to noncontrolling investors in joint ventures
33
57
44
24
Other borrowings
15
20
25
1
Issuance of long-term debt
0
-
0
1,770
Proceeds from abl facility
585
123
0
832
Repayments of long-term indebtedness
1,193
351
244
2,892
Net cash used in financing activities
-628
-274
-271
-321
Net change in cash and cash equivalents
-563
452
137
-333
Cash and cash equivalents at beginning of period
712
260
123
37
Cash and cash equivalents at end of period
149
712
260
123
Page 1
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net operating
revenues
$2,825M
(-55.10%↓ Y/Y)
Impairment and (gain) loss
on sale of...
-$172M
(34.60%↑ Y/Y)
Equity in earnings of
unconsolidated affiliates
$2M
(-50.00%↓ Y/Y)
Interest income
$1M
(0.00%↑ Y/Y)
Depreciation and
amortization
$108M
(-48.82%↓ Y/Y)
Net income
$104M
(-69.86%↓ Y/Y)
Supplies, prepaid
expenses and other...
-$77M
(-692.31%↓ Y/Y)
Other non-cash
expenses, net
-$40M
(56.52%↑ Y/Y)
Accounts payable,
accrued liabilities and...
$6M
(-86.96%↓ Y/Y)
Loss (gain) from
early extinguishment...
-$4M
(-102.90%↓ Y/Y)
Stock-based compensation
expense
$2M
(-71.43%↓ Y/Y)
Canceled cashflow
$2,896M
Net cash (used in)
provided by operating...
$88M
(-57.69%↓ Y/Y)
Canceled cashflow
$253M
Salaries and benefits
$1,237M
(-54.17%↓ Y/Y)
Other segment items
$704M
(-53.00%↓ Y/Y)
Supplies
$402M
(-58.04%↓ Y/Y)
Interest expense
$207M
(-52.19%↓ Y/Y)
Medical specialist fees
$158M
(-49.68%↓ Y/Y)
Depreciation and
amortization
$108M
(-48.82%↓ Y/Y)
Provision for income taxes
$76M
(-52.50%↓ Y/Y)
Loss (gain) from
early extinguishment...
-$4M
(-102.90%↓ Y/Y)
Net change in cash
and cash...
-$563M
(-234.37%↓ Y/Y)
Canceled cashflow
$88M
Proceeds from abl
facility
$585M
(-73.28%↓ Y/Y)
Other borrowings
$15M
(0.00%↑ Y/Y)
Proceeds from
disposition of hospitals and...
$110M
(-89.14%↓ Y/Y)
Proceeds from sales of
available-for-sale debt securities...
$18M
(-68.97%↓ Y/Y)
Impairment and (gain) loss
on sale of...
-$172M
(34.60%↑ Y/Y)
Other
$63M
(1.61%↑ Y/Y)
Patient accounts
receivable
$18M
(-30.77%↓ Y/Y)
Net cash used in
financing activities
-$628M
(-9.22%↓ Y/Y)
Canceled cashflow
$600M
Net cash provided by
investing activities
-$23M
(-102.93%↓ Y/Y)
Canceled cashflow
$128M
Repayments of long-term
indebtedness
$1,193M
(-64.70%↓ Y/Y)
Distributions to
noncontrolling investors in...
$33M
(-65.63%↓ Y/Y)
Deferred financing costs
and other...
$2M
(0.00%↑ Y/Y)
Purchases of property and
equipment
$76M
(-56.82%↓ Y/Y)
Acquisitions of facilities
and other related...
$48M
Purchases of
available-for-sale debt securities...
$23M
(-68.06%↓ Y/Y)
Increase in other
investments
$3M
(-92.86%↓ Y/Y)
Purchases of investments
in unconsolidated...
$1M
Buy us a coffee
COMMUNITY HEALTH SYSTEMS INC (CYH)
COMMUNITY HEALTH SYSTEMS INC (CYH)